Next Article in Journal
Preparation and Characterization of Fenofibrate Microparticles with Surface-Active Additives: Application of a Supercritical Fluid-Assisted Spray-Drying Process
Next Article in Special Issue
Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline
Previous Article in Journal
Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor Therapy
Previous Article in Special Issue
Formulation and Development of Oral Fast-Dissolving Films Loaded with Nanosuspension to Augment Paroxetine Bioavailability: In Vitro Characterization, Ex Vivo Permeation, and Pharmacokinetic Evaluation in Healthy Human Volunteers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 13
Issue 12
10.3390/pharmaceutics13122059
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2021, 13(8), 1257.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257

by
Deanna M. Mudie
*,
Aaron M. Stewart
,
Jesus A. Rosales
†,
Molly S. Adam
,
Michael M. Morgen
and
David T. Vodak
Global Research & Development, Lonza, Bend, OR 97703, USA
*
Author to whom correspondence should be addressed.
†
Current address: Pharmaceutics Department, University of Washington, Seattle, WA 98195, USA.
Pharmaceutics 2021, 13(12), 2059; https://doi.org/10.3390/pharmaceutics13122059
Submission received: 19 November 2021 / Revised: 24 November 2021 / Accepted: 24 November 2021 / Published: 2 December 2021
(This article belongs to the Special Issue Solid Dispersions for Drug Delivery: Applications and Preparation Methods)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The authors wish to make the following corrections to this paper [...]

Share and Cite

MDPI and ACS Style

Mudie, D.M.; Stewart, A.M.; Rosales, J.A.; Adam, M.S.; Morgen, M.M.; Vodak, D.T. Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257. Pharmaceutics 2021, 13, 2059. https://doi.org/10.3390/pharmaceutics13122059

AMA Style

Mudie DM, Stewart AM, Rosales JA, Adam MS, Morgen MM, Vodak DT. Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257. Pharmaceutics. 2021; 13(12):2059. https://doi.org/10.3390/pharmaceutics13122059

Chicago/Turabian Style

Mudie, Deanna M., Aaron M. Stewart, Jesus A. Rosales, Molly S. Adam, Michael M. Morgen, and David T. Vodak. 2021. "Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257" Pharmaceutics 13, no. 12: 2059. https://doi.org/10.3390/pharmaceutics13122059

APA Style

Mudie, D. M., Stewart, A. M., Rosales, J. A., Adam, M. S., Morgen, M. M., & Vodak, D. T. (2021). Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257. Pharmaceutics, 13(12), 2059. https://doi.org/10.3390/pharmaceutics13122059

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop